跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atorpine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Atorpine
Approved
STANDARD
Atorpine
Stallion Laboratories Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
eadc64599db903cb
Company
Stallion Laboratories Pvt. Ltd
Type
Standard
Approval Details
Approval Id
eadc64599db903cb
Drug Approval Philippines Name
Atorpine
Product Name
Atorpine
Registration Number
DRP-2304-06
Brand Name
Atorpine
Generic Name
Amlodipine (As Besilate) + Atorvastatin (As Calcium)
Dosage Form
Tablet
Dosage Strength
10 mg/ 10 mg
Manufacturer
Stallion Laboratories Pvt. Ltd
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals, Inc.
Issuance Date
25 October 2022
Expiry Date
07 July 2028
Pharmacologic Category
Calcium Channel Blocker/HMG CoA Reductase Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
eadc64599db903cb
Type
Standard
Back to Philippines FDA Approvals